A new regimen of MESNA (2-mercaptoethanesulfonate) effectively prevents cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplant recipients

Transplantation Proceedings

Volumn 32, Issue 3, 2000, Pages 596-

  Khojasteh, N H ^a   Zakerinia, M ^a   Ramzi, M ^a   Haghshenas, M ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; DIURETIC AGENT; MESNA;

ACUTE LEUKEMIA; ADULT; APLASTIC ANEMIA; BLADDER IRRIGATION; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CONFERENCE PAPER; DRUG EFFICACY; GRAFT VERSUS HOST REACTION; HEMATURIA; HEMORRHAGIC CYSTITIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL; SCHOOL CHILD; THALASSEMIA MAJOR; TREATMENT INDICATION;

BONE MARROW TRANSPLANTATION; CYCLOPHOSPHAMIDE; CYSTITIS; HEMORRHAGE; HUMANS; MESNA; POSTOPERATIVE COMPLICATIONS; PROTECTIVE AGENTS;

EID: 0343238462     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(00)00906-4     Document Type: Conference Paper

References (6)

1. Vose JM, Reed EC, Pippert GC: J Clin Oncol 11:1306, 1993
2. Haselberger MB, Schwinghammer TL: Ann Pharmacother 20:918, 1995
3. Turkeri LN, Lum LG, Uberti JP, et al: J Urol 153:637, 1995
4. Lanzkowsky P: Manual of Pediatric Hematology and Oncology, 1989
5. Russel SJ, Vowels MR, Vale T: Bone Marrow Transplant 13:533, 1994
6. Erer B, Angelucci E, Baronciani D, et al: Bone Marrow Transplant 12(suppl 1):93, 1993